Shanghai IxCell Biotechnology Co., Ltd.

Founded on August 29, 2013, IxCell Biotechnology Co., Ltd (“IxCell”) is a biopharmaceutical company focused on the research and manufacturing of cell therapy products. Our vision is to improve general public health through research and development in the cell therapy field. We have established a 4,000 m2 production base integrating R&D and manufacture in the Zhangjiang High Tech Zone. Our founding and core team members come from top international research institutions,such as Harvard University and Yale University, as well as leading biotech companies. Through independent research and development, our team has formed China’s first stem cell preparation process development system and the first standardized and large-scale stem cell manufacture system that meets China’s Current Good Manufacturing Practice (“cGMP”) requirements.